オクラホマにおける乳がんの臨床試験
オクラホマ内の拠点で、乳がんに関する20件の研究が参加者を募集しています。
オクラホマ内の都市
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Oklahoma, Oklahoma City
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Oklahoma City, Oklahoma City
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- Oklahoma Proton Center, Oklahoma City
被験者募集中第2相
50歳以上 · 女性 · 2026/09/29更新 · NCT01766297Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Oklahoma City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05867251Biopsy-site-marker in Breast Cancer
- OU Health Stephenson Cancer Center, Oklahoma City
被験者募集中観察研究
18歳以上 · 女性 · 2026/09/22更新 · NCT07833566A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Oklahoma Cancer Specialists and Research Institute (OCSRI) - Tulsa Cancer Center, Tulsa
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616A Phase 1/1b Study of IAM1363 in HER2 Cancers
- OU Health Stephenson Cancer Center, Oklahoma City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871The Vanguard Study: Testing a New Way to Screen for Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Cancer Centers of Southwest Oklahoma Research, Lawton
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
被験者募集中第3相
18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06500481Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Oklahoma - Health Sciences Center, Oklahoma City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05579366E-Mindfulness Approaches for Living After Breast Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中第3相
18歳〜50歳 · 全性別 · 2026/08/04更新 · NCT06748222A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Stephenson Cancer Center Oklahoma University Health, Oklahoma City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT05377996De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
被験者募集中第3相
50歳〜70歳 · 全性別 · 2026/04/23更新 · NCT04852887Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Mercy Hospital Oklahoma City, Oklahoma City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
- Stephenson Cancer Center, Oklahoma City
- Stephenson Cancer Center- Tulsa, Tulsa
被験者募集中早期第1相
18歳〜99歳 · 全性別 · 2026/01/26更新 · NCT05921253Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
- OU Health Stephenson Cancer Center, Oklahoma City
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/17更新 · NCT07014618SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
- Exelixis Clinical Site #13, Oklahoma City
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/05更新 · NCT05932862BostonGene and Exigent Genomic INsight Study
- Oklahoma Cancer Specialists and Research Institute, Tulsa
被験者募集中観察研究
18歳以上 · 全性別 · 2025/02/17更新 · NCT06272864ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。